A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sung Yong Lee, MD, PhD
Korea University Guro Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kosin University Gospel Hospital
Busan, South Korea
Tae Won Jang, MD, PhDRecruiting - Keimyung University Dongsan Hospital
Daegu, South Korea
Sun Hyo Park, MD, PhDRecruiting - Kyungpook National University Medical Center
Daegu, South Korea
Recruiting - Chungnam National University Hospital
Daejeon, South Korea
Jeong Eun Lee, MD, PhDRecruiting - Chonnam National University Hospital Hwasun Hospital
Gwangju, South Korea
In-Jae Oh, MD, PhDRecruiting - Inha University Hospital
Incheon, South Korea
Jun Hyeok Lim, MD, MSRecruiting - Pusan National University Yangsan Hospital
Pusan, South Korea
Recruiting - Asan Medical Center
Seoul, South Korea
Chang-Min Choi, MD, PhDRecruiting - Hanyang University Seoul Hospital
Seoul, South Korea
Dong Won Park, MD, PhDRecruiting - Koera University Guro Hospital
Seoul, South Korea
Juwhan Choi, MD, PhDSung Yong Lee, MD, PhDRecruiting - Korea University Anam Hospital
Seoul, South Korea
Recruiting - Kyung Hee University Hospital
Seoul, South Korea
Seung Hyeun Lee, MD, PhDRecruiting - Yonsei University Health System, Severance Hospital
Seoul, South Korea
Eunyoung Kim, MD, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2022
- Primary completion
- 2 Mar 2026
- Completion
- 2 Mar 2026
- Last update posted
- 1 Sept 2023
- Registered enrollment
- 77
- Registry id
- NCT05338619
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.